Frontiers in Medicine,
Journal Year:
2021,
Volume and Issue:
8
Published: Nov. 16, 2021
Background:
Invasive
pulmonary
aspergillosis
(IPA)
is
a
life-threatening
complication
in
coronavirus
disease
2019
(COVID-19)
patients
admitted
to
intensive
care
units
(ICUs),
but
risk
factors
for
COVID-19-associated
IPA
(CAPA)
have
not
been
fully
characterized.
The
aim
of
the
current
study
was
identify
associated
with
CAPA,
and
assess
long-term
mortality.
Methods:
A
retrospective
cohort
adult
COVID-19
ICUs
from
six
hospitals
conducted
Hubei,
China.
CAPA
diagnosed
via
composite
clinical
criteria.
Demographic
information,
variables,
180-day
outcomes
after
diagnosis
were
analyzed.
Results:
Of
335
critically
ill
COVID-19,
78
(23.3%)
developed
within
median
20.5
days
(range
13.0-42.0
days)
symptom
onset.
Compared
those
without
more
likely
thrombocytopenia
(50
vs.
19.5%,
p
<
0.001)
secondary
bacterial
infection
prior
being
(15.4
6.2%,
=
0.013),
receive
vasopressors
(37.2
8.6%,
0.001),
higher
steroid
dosages
(53.9
34.2%,
0.002),
renal
replacement
therapy
13.6%,
invasive
mechanical
ventilation
(57.7
35.8%,
0.001).
In
multivariate
analysis
incorporating
hazard
ratios
(HRs)
confidence
intervals
(CIs),
(HR
1.98,
95%
CI
1.16-3.37,
0.012),
vasopressor
use
3.57,
1.80-7.06,
methylprednisolone
at
daily
dose
≥
40
mg
1.69,
1.02-2.79,
1.02-2.79)
before
independently
CAPA.
Patients
had
longer
ICU
stays
(17
12
days,
0.007),
mortality
(65.4
33.5%,
than
Conclusions:
Thrombocytopenia,
use,
corticosteroid
treatment
significantly
increased
incident
ICUs.
occurrence
may
increase
likelihood
Annals of Intensive Care,
Journal Year:
2020,
Volume and Issue:
10(1)
Published: Aug. 8, 2020
Abstract
Background
The
COVID-19
pandemic
has
resulted
in
an
unprecedented
healthcare
crisis
with
a
high
prevalence
of
psychological
distress
providers.
We
sought
to
document
the
burnout
syndrome
amongst
intensivists
facing
outbreak.
Methods
Cross-sectional
survey
among
part
European
Society
Intensive
Care
Medicine.
Symptoms
severe
burnout,
anxiety
and
depression
were
collected.
Factors
independently
associated
assessed
using
Cox
model.
Results
Response
rate
was
20%
(1001
completed
questionnaires
returned,
45
years
[39–53],
34%
women,
from
85
countries,
12
regions,
50%
university-affiliated
hospitals).
symptoms
or
46.5%,
30.2%,
51%,
respectively,
varied
significantly
across
regions.
Rating
relationship
between
other
ICU
stakeholders
differed
according
presence
anxiety,
depression,
burnout.
Similar
figures
reported
for
their
rating
ethical
climate
quality
decision-making.
female
gender
(HR
1.85
[1.33–2.55]),
working
hospital
0.58
[0.42–0.80]),
living
city
>
1
million
inhabitants
1.40
[1.01–1.94]),
clinician’s
0.83
[0.77–0.90]).
Independent
determinants
included
1.63
[1.15–2.31])
0.84
[0.78–0.92]).
age
0.98/year
[0.97–0.99])
0.76
[0.69–0.82]).
Conclusions
had
overwhelming
impact
on
intensivists.
Follow-up,
management
are
warranted
assess
long-term
outcomes
alleviate
burden
frontline
personnel.
Critical Care,
Journal Year:
2020,
Volume and Issue:
24(1)
Published: July 6, 2020
The
global
numbers
of
confirmed
cases
and
deceased
critically
ill
patients
with
COVID-19
are
increasing.
However,
the
clinical
course,
60-day
mortality
its
predictors
in
have
not
been
fully
elucidated.
aim
this
study
is
to
identify
COVID-19.
Critically
adult
admitted
intensive
care
units
(ICUs)
from
3
hospitals
Wuhan,
China,
were
included.
Data
on
demographic
information,
preexisting
comorbidities,
laboratory
findings
at
ICU
admission,
treatments,
outcomes,
results
SARS-CoV-2
RNA
tests
serum
IgM
collected
including
duration
between
symptom
onset
negative
conversion
RNA.
Of
1748
COVID-19,
239
(13.7%)
Complications
included
acute
respiratory
distress
syndrome
(ARDS)
164
(68.6%)
patients,
coagulopathy
150
(62.7%)
cardiac
injury
103
(43.1%)
kidney
(AKI)
119
(49.8%)
which
occurred
15.5
days,
17
18.5
19
days
after
onset,
respectively.
median
was
30
(range
6-81)
49
survivors
that
identified.
A
total
147
(61.5%)
by
60
admission.
admission
decease
12
3-36).
Cox
proportional-hazards
regression
analysis
revealed
age
older
than
65
years,
thrombocytopenia
ARDS,
AKI
independently
predicted
mortality.
Severe
complications
common
considerably
high.
association
severity
should
be
seriously
considered
further
studied.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: June 30, 2021
More
than
one
year
since
its
emergence,
corona
virus
disease
2019
(COVID-19)
is
still
looming
large
with
a
paucity
of
treatment
options.
To
add
to
this
burden,
sizeable
subset
patients
who
have
recovered
from
acute
COVID-19
infection
reported
lingering
symptoms,
leading
significant
disability
and
impairment
their
daily
life
activities.
These
are
considered
suffer
what
has
been
termed
as
“chronic”
or
“long”
form
post-acute
sequelae
COVID-19,
experiencing
syndrome
long-haulers.
Despite
recovery
infection,
the
persistence
atypical
chronic
including
extreme
fatigue,
shortness
breath,
joint
pains,
brain
fogs,
anxiety
depression,
that
could
last
for
months
implies
an
underlying
pathology
persist
beyond
presentation
disease.
As
opposed
direct
effects
itself,
immune
response
severe
respiratory
coronavirus
2
(SARS-CoV-2)
believed
be
largely
responsible
appearance
these
lasting
possibly
through
facilitating
ongoing
inflammatory
process.
In
review,
we
hypothesize
potential
immunological
mechanisms
persistent
prolonged
effects,
describe
multi-organ
long-term
manifestations
COVID-19.
Critical Care,
Journal Year:
2020,
Volume and Issue:
24(1)
Published: May 14, 2020
A
COVID-19
outbreak
started
in
Wuhan,
China,
last
December
and
now
has
become
a
global
pandemic.
The
clinical
information
caring
of
critically
ill
patients
with
needs
to
be
shared
timely,
especially
under
the
situations
that
there
is
still
largely
ongoing
spread
many
countries.A
multicenter
prospective
observational
study
investigated
all
received
19
ICUs
16
hospitals
over
24
h
between
8
AM
February
2h
27,
2020.
demographic
information,
characteristics,
vital
signs,
complications,
laboratory
values,
managements
were
studied.A
total
226
included.
Their
median
(interquartile
range,
IQR)
age
was
64
(57-70)
years,
139
(61.5%)
male.
duration
from
date
ICU
admission
11
(5-17)
days,
onset
symptoms
31
(24-36)
days.
Among
patients,
155
(68.6%)
had
at
least
one
coexisting
disease,
their
sequential
organ
failure
assessment
score
4
(2-8).
Organ
function
damages
found
most
patients:
ARDS
161
(71.2%)
septic
shock
34
(15.0%)
acute
kidney
injury
occurred
57
(25.2%)
cardiac
61
(27.0%)
lymphocytopenia
160
(70.8%)
patients.
Of
studied
85
(37.6%)
invasive
mechanical
ventilation,
including
14
(6.2%)
treated
extracorporeal
membrane
oxygenation
(ECMO)
same
time,
20
(8.8%)
noninvasive
(10.6%)
continuous
renal
replacement
therapy.
By
April
9,
2020,
87
(38.5%)
deceased
15
(6.7%)
hospital.Critically
are
associated
higher
risk
severe
complications
need
receive
an
intensive
level
treatments.
poses
great
strain
on
critical
care
resources
hospitals.Chinese
Clinical
Trial
Registry,
ChiCTR2000030164.
Registered
24,
http://www.chictr.org.cn/edit.aspx?pid=49983&htm=4.
Annals of Global Health,
Journal Year:
2021,
Volume and Issue:
87(1), P. 44 - 44
Published: May 18, 2021
Background:
Coronavirus
Disease
2019
(COVID-19)
became
the
deadliest
pandemic
of
new
millennium.
One
year
after
it
a
pandemic,
current
COVID-19
situation
in
Brazil
is
an
example
how
impacts
are
beyond
health
outcomes
and
health,
social,
political
actions
intertwined.
Objectives:
We
aimed
to
provide
overview
first
Brazil,
from
social
point
view,
discuss
perspectives
now
on.
Methods:
This
narrative
review
using
official,
scientific
(PubMed,
Medline,
SciELO
databases)
publicly
available
data.
Press
articles
were
also
used
that
contain
important
information
not
found
these
databases.
Findings:
address
different
regions
on
indigenous
populations,
care
workers,
internal
contrasts
impacted
pandemic's
advance
across
country.
key
points
culminated
country's
failed
management
spread,
such
as
poor
public
system,
disparities
between
private
infrastructure,
lack
mass
testing
viral
spread
tracking,
preparedness
planning
implement
strict
isolation
distancing
measures,
and,
most
importantly,
instability,
deteriorating
Health
Ministry
sabotaging
attitudes
president,
including
anti-scientific
actions,
underplaying
severity,
spreading
powering
fake
news
about
promoting
knowingly
inefficient
medications
for
treatment,
interference
collective
policies,
vaccination
plan.
Conclusions:After
one
disastrous
disease,
has
more
than
11
million
cases,
270,000
deaths,
highest
number
daily
deaths
due
world,
which
could
have
been
avoided
can
be
credited
negligence
municipal,
state,
federal
authorities,
especially
President
Jair
Messias
Bolsonaro.
Unfortunately,
country
what
do
setting.
Key
Points:
One
was
declared
had
second
higher
cases
disease.
Lack
massive
testing,
non-stringent
ineffective
instability
main
drivers
flawed
advancement.
Anti-science
by
government
pivotal
role
situation.
Brazil
large
territory
marked
among
states,
showed
contrasting
data
regarding
impact
caused
COVID-19.
COVID-19
databases
sharing
epidemiological
aspects
disease;
however,
lacks
standardization
datasets.
Heart & Lung,
Journal Year:
2021,
Volume and Issue:
50(5), P. 599 - 608
Published: May 1, 2021
Pneumothorax
has
been
frequently
described
as
a
complication
of
COVID-19
infections.In
this
systematic
review,
we
describe
the
incidence,
clinical
characteristics,
and
outcomes
COVID-19-related
pneumothorax.Studies
were
identified
through
MEDLINE,
Pubmed,
Google
Scholar
databases
using
keywords
"COVID-19,"
"SARS-CoV-2,"
"pneumothorax,"
"pneumomediastinum,"
"barotrauma"
from
January
1st,
2020
to
30th,
2021.Among
nine
observational
studies,
incidence
pneumothorax
is
low
at
0.3%
in
hospitalized
patients.
However,
increases
12.8-23.8%
those
requiring
invasive
mechanical
ventilation
(IMV)
with
high
mortality
rate
up
100%.
tends
be
unilateral
right-sided.
Age,
pre-existing
lung
diseases,
active
smoking
status
are
not
shown
risk
factors.
The
time
diagnosis
around
9.0-19.6
days
admission
5.4
after
IMV
initiation.
pneumothoraces
associated
prolonged
hospitalization,
increased
likelihood
ICU
death,
especially
among
elderly.COVID-19-related
likely
signify
greater
disease
severity.
With
variability
described,
well-designed
study
required
better
assess
significance
pneumothorax.
Annals of Medicine and Surgery,
Journal Year:
2021,
Volume and Issue:
62, P. 68 - 72
Published: Jan. 10, 2021
COVID-19
virus
involves
respiratory
as
well
other
body
systems
including
cardiovascular,
gastrointestinal,
neurological,
immunological
and
hematopoietic
system.
Patient
of
covid-19
pneumonia
presents
with
wide
range
hemostatic
abnormalities.
These
abnormalities
in
are
related
disease
progression,
severity
mortality.
The
Objective
our
study
is
to
evaluate
the
role
hematological
parameters
determination
severity.This
was
a
retrospective
study,
conducted
Department
Pathology
medicine,
FMH
college
Medicine
Dentistry
from
May
2020
July
2020.
Total
101,
confirmed
cases
disease,
both
genders
between
17
75-year
age
were
included.
Hematological
compared
mild,
moderate,
severe
critical
group.
Continuous
variables
analyzed
by
using
non
parametric,
Kruskal
Wallis
test
while
categorical
chi-square
test.Out
101
patients,
20.8%,
51.8%,19.8%
7.9%
group
respectively.
Median
(IQR)
values
WBCs
(p-value
0.004),
ANC
0.002),
NLR
0.001),
D-dimer
level
ferritin
(0.0001),
LDH
(0.0001)
significantly
increased
patients
disease.
APTT
0.003)
CRP
(p-
value
0.0001)
suggestively
higher
Other
like
Hemoglobin,
MCV,
HCT,
ALC,
Platelet
count,
prothrombin
time
did
not
show
statistically
significant
association
disease.The
concluded
that
Leukocytosis,
neutrophilia,
elevated
Neutrophil
lymphocyte
ratio,
APTT,
D-dimer,
serum
associated
PLoS ONE,
Journal Year:
2021,
Volume and Issue:
16(4), P. e0249346 - e0249346
Published: April 16, 2021
Coronavirus
disease
2019
(COVID-19)
is
a
serious
illness
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
and
in
cases
associated
with
distress
(ARDS).To
describe
the
clinical
characteristics
of
patients
ARDS-COVID-19.This
study
involved
197
male
Egyptian
participants,
among
them111
COVID-19
presented
ARDS,
60
non-ARDS,
26
Non-COVID-19
patients.
We
reported
analysis
results
laboratory
information,
including
blood
routine
tests,
biochemistry
parameters
[aspartate
aminotransferase
(AST),
alanine
(ALT),
creatinine
C-reactive
protein
(CRP)],
thrombotic
activity
(D-dimer)
serum
ferritin
lactate
dehydrogenase
(LDH).The
levels
hemoglobin,
AST,
creatinine,
monocyte
count,
%,
RBC
TLC,
platelet
count
were
not
significantly
different
groups.
The
lymphopenia
increased
CRP,
ALT,
D-dimer,
ferritin,
LDH
observed
ARDS-COVID-19.COVID-19
ARDS
lymphopenia,
activity,
LDH,
levels.
revealed
that
levels,
have
significant
association
severity
can
be
used
as
biomarkers
to
predict
severity.